ClinVar Miner

Submissions for variant NM_000310.4(PPT1):c.272A>C (p.Gln91Pro)

gnomAD frequency: 0.00001  dbSNP: rs386833639
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000049598 SCV000800701 uncertain significance Neuronal ceroid lipofuscinosis 1 2018-04-25 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000049598 SCV001415148 pathogenic Neuronal ceroid lipofuscinosis 1 2024-01-29 criteria provided, single submitter clinical testing This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 91 of the PPT1 protein (p.Gln91Pro). This variant is present in population databases (rs386833639, gnomAD 0.02%). This missense change has been observed in individual(s) with neuronal ceroid lipofuscinosis (PMID: 17044973; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 56187). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PPT1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV004700344 SCV005202646 uncertain significance not specified 2024-07-11 criteria provided, single submitter clinical testing Variant summary: PPT1 c.272A>C (p.Gln91Pro) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251460 control chromosomes. c.272A>C has been reported in the literature in the homozygous state in at least 1 individual affected with Neuronal Ceroid-Lipofuscinosis (Batten Disease) (example, Bi_2006). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 17044973). ClinVar contains an entry for this variant (Variation ID: 56187). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM) RCV000049598 SCV000082005 probable-pathogenic Neuronal ceroid lipofuscinosis 1 no assertion criteria provided not provided Converted during submission to Likely pathogenic.
Natera, Inc. RCV000049598 SCV002086004 uncertain significance Neuronal ceroid lipofuscinosis 1 2020-04-17 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.